EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study

The regulator has declined to approve a nasal spray that would have been the first needle-free emergency treatment for allergic reactions.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pediatrics News Source Type: news